Nottingham pharma software firm lands £500,000 investment deal
A Nottingham business which is developing new software to help pharmaceutical companies to manage clinical trials more effectively has secured a £500,000 equity investment from Mercia Fund Managers and angel investors.
PHARMASEAL International was established in 2016 by Daljit Cheema and Sara Rutner. The pair have previously held senior roles at pharma IT specialists ClinPhone Group and PAREXEL.
The two founders say they have already developed a prototype product, and the funding will allow them to roll out their first module â... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
